Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,774
datasets available to search
ShareScore release 0.9.0
Dataset results
2,774 results for “Agent”
Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent
ClinicalTrials.gov study NCT02431650. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy
ClinicalTrials.gov study NCT03334617. IPD Sharing: YES. Countries: 8. Publications: 1.
A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
ClinicalTrials.gov study NCT04550104. IPD Sharing: YES. Countries: 1. Publications: 3.
A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00655668. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia
ClinicalTrials.gov study NCT04707768. IPD Sharing: NO. Countries: 1. Publications: 2.
Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass
ClinicalTrials.gov study NCT00585013. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Optical Properties of Light Cured Luting Agent on Laminate Veneer
ClinicalTrials.gov study NCT02464540. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas
ClinicalTrials.gov study NCT02448537. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03269136. IPD Sharing: NO. Countries: 2. Publications: 3.
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
ClinicalTrials.gov study NCT04936308. IPD Sharing: YES. Countries: 14. Publications: 1.
A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab
ClinicalTrials.gov study NCT01307267. IPD Sharing: NO. Countries: 5. Publications: 2.
LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma
ClinicalTrials.gov study NCT02159066. IPD Sharing: YES. Countries: 9. Publications: 1.
Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
ClinicalTrials.gov study NCT00113269. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001)
ClinicalTrials.gov study NCT02761694. IPD Sharing: YES. Countries: 1. Publications: 1.
First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent
ClinicalTrials.gov study NCT05413668. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
ClinicalTrials.gov study NCT00299546. IPD Sharing: Not stated. Countries: 10. Publications: 4.
Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery
ClinicalTrials.gov study NCT04246554. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD
ClinicalTrials.gov study NCT02884908. IPD Sharing: YES. Countries: 1. Publications: 17.
A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma
ClinicalTrials.gov study NCT01320085. IPD Sharing: YES. Countries: 5. Publications: 1.
Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients
ClinicalTrials.gov study NCT00354484. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.